These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 505367)

  • 1. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
    Lewis GP; Westwick J
    Br J Pharmacol; 1975 Oct; 55(2):255P-256P. PubMed ID: 1201396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis.
    Philp RB; Francey I; Warren BA
    Haemostasis; 1978; 7(5):282-93. PubMed ID: 689491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of antithrombotic drugs ex vivo and in vivo.
    Buchanan M; Hirsh J
    Bibl Anat; 1977; (16 Pt 2):208-11. PubMed ID: 603518
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
    Harker LA; Hanson SR
    J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pyrimido-pyrimidine compounds on platelet function.
    Cucuianu MP; Nishizawa EE; Mustard JF
    J Lab Clin Med; 1971 Jun; 77(6):958-74. PubMed ID: 5559863
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon on the formation of experimental coagulation thrombi].
    Zimmermann R; Barth P; Masche R
    Verh Dtsch Ges Inn Med; 1974; 80():1446-8. PubMed ID: 4454451
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelets in fibrinolytic system.
    Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1995 Dec; 46(4):409-18. PubMed ID: 8770785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.
    Hampton JR; Harrison MJ; Honour AJ; Mitchell JR; Prichard JS
    Cardiovasc Res; 1972 Nov; 6(6):696-701. PubMed ID: 4656476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.